Australian Local Sponsor
Where Tricode accepts the appointment, Tricode acts as the Australian clinical trial sponsor for the agreed study and assumes the Australian sponsor responsibilities defined for that engagement.
Australian Local Sponsor & Regulatory Support
Australian Local Sponsor Support for Clinical Trials
Tricode Clinical provides Australian Local Sponsor and regulatory support for international pharmaceutical and biotechnology companies conducting clinical trials in Australia.
Where the study and operating model are appropriate, Tricode can accept appointment as the Australian clinical trial sponsor and work alongside the global sponsor, existing CRO, sites and specialist providers without requiring the established delivery model to be replaced.
Why an Australian Trial Sponsor Is Required
Clinical trials conducted in Australia require an Australian trial sponsor. For an overseas company without a suitable Australian entity, this is an early regulatory and operating-model decision.
Where the study, scope and operating model are appropriate, Tricode can accept appointment as the Australian clinical trial sponsor.
- International sponsors opening Australia within a global development program
- Biotechnology companies without an Australian sponsor entity
- Sponsors retaining a CRO that does not provide the Australian sponsor role
- CTN, CTA or advanced-therapy programs requiring coordinated Australian oversight
Acting as the Australian Clinical Trial Sponsor
“Local Sponsor” commonly describes an Australian organisation that assumes the Australian clinical trial sponsor role for an overseas sponsor, including responsibility for the CTN or CTA submission to the TGA.
Functions may be delegated to appropriately qualified providers, but delegation does not remove sponsor responsibility. Roles, information flows and oversight must therefore be clearly established.
Keep Your Existing CRO and Delivery Model
Appointing Tricode as Australian Local Sponsor does not require the sponsor to replace its existing CRO or other clinical delivery partners.
The global sponsor can retain program leadership while the CRO continues agreed operational activities. Tricode can provide the Australian sponsor and regulatory interface through defined responsibilities and information flows.
Monitoring, medical monitoring, pharmacovigilance, data management, logistics and other specialist functions can remain with qualified providers. Delegation does not remove appropriate sponsor oversight.
The objective is a clear Australian sponsor model that integrates with the sponsor’s existing global infrastructure.
Australian clinical trial operating model
Global Development SponsorGlobal program leadership and infrastructure
Defined responsibilities and information flow
Australian Trial Sponsor role
Tricode Clinical
Sponsor oversight, Australian regulatory judgement and coordination where appointed
Delegation, coordination and oversight
CRO / Specialist ProvidersAgreed operational and specialist activities
Australian Investigators / SitesSite-level trial delivery and institutional requirements
External regulatory and governance interfaces
TGA
HREC
OGTR / IBC where relevant
Australian Sponsor and Regulatory Support Across the Study
The precise scope is defined for each study according to the product, pathway, study design and responsibilities retained by the global sponsor and its providers.
Sponsor Role & Regulatory Strategy
- Australian clinical trial sponsor role where accepted
- Australian regulatory strategy and CTN or CTA pathway assessment
Study Start-Up & Australian Interfaces
- CTN or CTA preparation and submission support
- HREC, institutional and site regulatory interfaces
- Australian study activation and regulatory readiness
Sponsor Oversight & Study Maintenance
- Definition of sponsor, CRO and provider responsibilities
- Oversight of delegated Australian activities
- Sponsor oversight and escalation of relevant safety, quality and regulatory matters
- Australian sponsor judgement on study issues and changes
Changes, Close-Out & Complex Programs
- Amendments, additional sites and material study changes
- Suspension, close-out and sponsor transfer where relevant
- OGTR, IBC and advanced-therapy coordination where applicable
Different Roles for Different Australian Needs
Regulatory Agent
Where Tricode is not appointed as the Australian trial sponsor, Tricode can provide defined Australian regulatory representation, coordination and TGA-facing support within the authority agreed for the engagement. Regulatory Agent support does not transfer the Australian clinical trial sponsor role to Tricode.
The exact authority and responsibilities are confirmed for each engagement.
A Defined Australian Sponsor Model
01 · ASSESS
Confirm the Australian Requirements
Review the product, study, pathway, operating model and sponsor requirements.
02 · DEFINE
Establish Responsibilities
Clarify responsibilities across Tricode, the global sponsor, CRO, sites and providers.
03 · ESTABLISH
Put the Australian Sponsor Workstream in Place
Progress agreed CTN/CTA, HREC, site and sponsor-readiness activities.
04 · OVERSEE
Maintain Australian Sponsor Oversight
Support maintenance, change, escalation, delegated-provider oversight and close-out.
Advanced Therapies and Additional Australian Interfaces
Some Australian trials require additional regulatory planning beyond the CTN or CTA and HREC workstreams. For gene therapy, genetically modified cell therapy and other programs involving gene technology, Tricode can coordinate the Australian sponsor workstream with applicable OGTR and IBC requirements.
Explore OGTR & Advanced Therapies →Why Tricode Clinical
Specialist Australian Regulatory Support
Australian-specific support across CTN, CTA, start-up and sponsor requirements.
Works With Your Existing CRO and Providers
An Australian sponsor and regulatory interface that fits the selected delivery model.
Continuity Across the Australian Workstream
Support from early strategy through maintenance, change and close-out.
Advanced-Therapy Capability Where Relevant
OGTR, IBC and advanced-therapy interfaces can be integrated where applicable.
Related Australian Regulatory Support
Planning an Australian Clinical Trial?
Tricode can help define an Australian sponsor or Regulatory Agent model that works with the existing CRO and providers.
Scope and suitability are assessed for each study before Tricode accepts an Australian sponsor appointment.
